Nuclear Tau Function
Nuclear Tau Function - Related Videos
08:05
Small-scale Nuclear Extracts for Functional Assays of Gene-expression Machineries
0 Views •
Cited by 36 •
2012
A protocol for preparation of robust, small-scale HeLa nuclear extracts is described. This protocol is valuable for assays that require use of small populations of cells, such as cells treated with drugs or RNAi. The method should be applicable to a wide variety of gene expression assays and other cell types, including patient cells.
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
0 Views •
Cited by 21 •
2015
Unmodified and hyperphosphorylated tau proteins were used in two in vitro aggregation assays to reveal the hyperphosphorylation-dependent fast aggregation kinetics. These assays pave the way for future screens for compounds that can modulate the propensity of hyperphosphorylated tau to form fibrils that underlie the progression of Alzheimer’s disease.
04:36
Production of Synthetic Nuclear Melt Glass
0 Views •
Cited by 1 •
2016
A protocol for the production of synthetic nuclear melt glass, similar to trinitite, is presented.
07:24
A Split-Luciferase Complementation Assay for Temporally Resolved Measurement of Tau Clearance in Microglia
0 Views •
2026
We describe a sensitive, time-resolved quantitative platform to measure clearance of extracellular tau in human induced pluripotent stem cell (iPSC)-derived microglia using a microplate-based luminescence system. This approach enables sensitive detection of tau degradation kinetics in a microwell format, allowing for high-throughput interrogation of tau handling under various experimental conditions.
12:55
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
0 Views •
Cited by 11 •
2017
This manuscript describes standard protocols for measuring tau hyperphosphorylation, measuring tau binding to microtubules, and localization of intracellular tau following drug treatments. These protocols can be used repetitively for screening drugs or other compounds that target tau hyperphosphorylation or microtubule binding.
FAQs
Charge-dependent interactions help determine which nuclear partners tau can associate with and how strongly those associations are maintained. Changes in tau’s charge or local environment could therefore alter its relationships with chromatin, DNA, or nucleolar components. This mechanism gives researchers a way to connect tau’s molecular properties with changes in chromatin organization, gene regulation, or protection of genomic material.
Alternative tau isoforms provide a genetic route for producing tau variants with potentially different nuclear behaviors. Studying them links regulation of the MAPT gene to the amount and form of tau available in the nucleus. Comparing isoforms can help determine whether changes in nuclear organization, gene regulation, or genomic protection depend on tau composition rather than tau presence alone.
Disease-associated mutations can be examined as perturbations of nuclear tau function. Researchers can compare how altered tau relates to DNA, chromatin, or nucleolar components and then assess whether those differences coincide with disrupted nuclear organization or reduced neuronal survival. This approach places mutation effects within a mechanistic chain from MAPT changes to cellular dysfunction.
The established microtubule role concerns neuronal structural support, whereas nuclear tau research examines relationships with DNA, chromatin, and nucleolar components. This broader view asks whether tau also participates in genome-associated processes, including chromatin organization, gene regulation, and protection from damage. The comparison is useful because abnormal localization may affect neurons through mechanisms beyond microtubule instability.
A conceptual workflow starts by relating MAPT gene expression and alternative isoforms to tau’s nuclear presence. The analysis then considers associations with DNA, chromatin, and nucleolar components, followed by possible effects on chromatin organization, gene regulation, and genomic material. Finally, researchers can relate these nuclear changes to neuronal survival and disease-associated mutations.
Localization is important because tau may have different consequences depending on whether it is associated with neuronal microtubules or nuclear structures. Examining nuclear localization can help distinguish a change in tau distribution from a change in tau abundance. That distinction may clarify how abnormal tau positioning contributes to genome-related dysfunction and neurodegenerative disease.
Within genetics, Nuclear Tau Function connects MAPT gene expression, alternative tau isoforms, and disease-associated mutations. Researchers can use this framework to ask whether gene-level changes alter tau’s nuclear associations and, in turn, nuclear organization or neuronal survival. It helps translate changes in the MAPT-related genetic context into testable cellular consequences relevant to neurodegenerative disease.